Blood pressure and dementia.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 15876979)

Published in Panminerva Med on December 01, 2004

Authors

W H Birkenhäger1, J A Staessen

Author Affiliations

1: Erasmus University, Rotterdam, the Netherlands.

Articles by these authors

(truncated to the top 100)

Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet (1998) 6.20

Immediate and late benefits of treating very elderly people with hypertension: results from active treatment extension to Hypertension in the Very Elderly randomised controlled trial. BMJ (2011) 2.77

European Society of Hypertension practice guidelines for home blood pressure monitoring. J Hum Hypertens (2010) 2.06

Reference values for self-recorded blood pressure: a meta-analysis of summary data. Arch Intern Med (1998) 2.01

Influence of the presence of doctors-in-training on the blood pressure of patients: a randomised controlled trial in 22 teaching practices. J Hum Hypertens (2004) 1.99

What is "hypertension"? Lancet (1999) 1.99

Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients. Arch Intern Med (2000) 1.99

Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Circulation (2000) 1.98

Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group. J Hypertens (1998) 1.83

Blood pressure, cognitive functions, and prevention of dementias in older patients with hypertension. Arch Intern Med (2001) 1.77

Chinese trial on isolated systolic hypertension in the elderly. Systolic Hypertension in China (Syst-China) Collaborative Group. Arch Intern Med (2000) 1.69

Autonomic nervous function, arterial stiffness and blood pressure in patients with Type I diabetes mellitus and normal urinary albumin excretion. J Hum Hypertens (2004) 1.51

Effect of age on brachial artery wall properties differs from the aorta and is gender dependent: a population study. Hypertension (2000) 1.48

The relationships between left ventricular mass and daytime and night-time blood pressures: a meta-analysis of comparative studies. J Hypertens (1995) 1.45

Night-day blood pressure ratio and dipping pattern as predictors of death and cardiovascular events in hypertension. J Hum Hypertens (2009) 1.42

An epidemiological re-appraisal of the association between blood pressure and blood lead: a meta-analysis. J Hum Hypertens (2002) 1.40

[Cognitive impairment and dementia in hypertension; the effect of antihypertensive medication]. Ned Tijdschr Geneeskd (2000) 1.38

Non-invasive assessment of local arterial pulse pressure: comparison of applanation tonometry and echo-tracking. J Hypertens (2001) 1.25

Prognostic significance of serum creatinine and uric acid in older Chinese patients with isolated systolic hypertension. Hypertension (2001) 1.19

Should exercise blood pressure be measured in clinical practice? J Hypertens (1998) 1.08

The pulse pressure-to-stroke index ratio predicts cardiovascular events and death in uncomplicated hypertension. J Am Coll Cardiol (2001) 1.06

Advantages and disadvantages of the meta-analysis approach. J Hypertens Suppl (1996) 1.05

Independent prognostic value of the ambulatory arterial stiffness index and aortic pulse wave velocity in a general population. J Hum Hypertens (2007) 1.04

Genetic polymorphisms in the renin-angiotensin system: relevance for susceptibility to cardiovascular disease. Eur J Pharmacol (2000) 1.04

The international database of self-recorded blood pressures in normotensive and untreated hypertensive subjects. Blood Press Monit (1999) 1.03

Properly defining white coat hypertension. Eur Heart J (2002) 1.00

Ambulatory blood pressure of adults in Novosibirsk, Russia: interim report on a population study. Blood Press Monit (2001) 0.98

Prediction of cardiac structure and function by repeated clinic and ambulatory blood pressure. Hypertension (1997) 0.97

The relationship between blood pressure and blood lead in NHANES III. National Health and Nutritional Examination Survey. J Hum Hypertens (2002) 0.97

Carotid and femoral artery stiffness in relation to three candidate genes in a white population. Hypertension (2001) 0.93

Impact of environmental cadmium pollution on cadmium exposure and body burden. Arch Environ Health (1992) 0.93

Cerebral complications of hypertension. J Hum Hypertens (2001) 0.93

Arterial structure and function and environmental exposure to cadmium. Occup Environ Med (2007) 0.91

For how many days should blood pressure be measured at home in older patients before steady levels are obtained? J Hum Hypertens (1997) 0.90

Treatment of isolated systolic hypertension in the elderly: the Syst-Eur trial. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Clin Exp Hypertens (1999) 0.90

Prognostic value of invasive hemodynamic measurements at rest and during exercise in hypertensive men. Hypertension (1996) 0.89

Follow-up of renal function in treated and untreated older patients with isolated systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. J Hypertens (2001) 0.89

Efficacy of different drug classes used to initiate antihypertensive treatment in black subjects: results of a randomized trial in Johannesburg, South Africa. Arch Intern Med (2001) 0.88

Influence of demographic, anthropometric and lifestyle characteristics on heart rate and its variability in the population. J Hypertens (1999) 0.88

Intracellular concentration and transmembrane fluxes of sodium and potassium in erythrocytes of white normal male subjects with and without a family history of hypertension. J Hypertens (1984) 0.85

Correlates of cognitive status of old patients with isolated systolic hypertension: the Syst-Eur Vascular Dementia Project. J Hypertens (1998) 0.85

Renal function in relation to three candidate genes. Am J Kidney Dis (2001) 0.83

Power spectral analysis of heart rate variability by autoregressive modelling and fast Fourier transform: a comparative study. Acta Cardiol (1998) 0.82

Relationships between changes in left ventricular mass and in clinic and ambulatory blood pressure in response to antihypertensive therapy. J Hypertens (1997) 0.82

Should pulse pressure become part of the Framingham risk score? J Hum Hypertens (2004) 0.81

Trough-to-peak versus surface ratio in the assessment of antihypertensive agents. APTH Investigators. Ambulatory Blood Pressure and Treatment of Hypertension. Blood Press (1995) 0.81

Associations of orthostatic blood pressure fall in older patients with isolated systolic hypertension. Syst-Eur Investigators. J Hypertens (1996) 0.81

Ambulatory blood pressure and left ventricular structure and function in relation to the G-protein beta3-subunit polymorphism C825T in White Europeans. J Hum Hypertens (2003) 0.81

Symptoms reported by elderly patients with isolated systolic hypertension: baseline data from the SYST-EUR trial. Systolic Hypertension in Europe. Age Ageing (1999) 0.80

Antihypertensive treatment modulates the association between the D/I ACE gene polymorphism and left ventricular hypertrophy: a meta-analysis. J Hum Hypertens (2000) 0.80

Systolic Hypertension in Europe (Syst-Eur) trial phase 2: objectives, protocol, and initial progress. Systolic Hypertension in Europe Investigators. J Hum Hypertens (1999) 0.80

Effects of antihypertensive treatment on endpoints in the diabetic patients randomized in the Systolic Hypertension in Europe (Syst-Eur) trial. J Nephrol (2000) 0.80

Efficacy of newer versus older antihypertensive drugs in black patients living in sub-Saharan Africa. J Hum Hypertens (2013) 0.80

Risks of smoking in treated and untreated older Chinese patients with isolated systolic hypertension. J Hypertens (2001) 0.80

Does B-mode common carotid artery intima-media thickness differ from M-model? Ultrasound Med Biol (2001) 0.80

Context-dependency of the relation between left ventricular mass and AGT gene variants. J Hum Hypertens (2005) 0.79

6C.05: STK39 AND WNK1 ARE POTENTIAL HYPERTENSION SUSCEPTIBILITY GENES IN THE BELHYPGEN COHORT. J Hypertens (2015) 0.79

Ambulatory blood pressure monitoring and postprandial hypotension in elderly patients with isolated systolic hypertension. Systolic Hypertension in Europe (SYST-EUR) Trial Investigators. J Hum Hypertens (1998) 0.79

Blood pressure and urinary sodium excretion in relation to the A-1984G adrenomedullin polymorphism in a Chinese population. Kidney Int (2006) 0.79

Dementia and statins. Lancet (2001) 0.79

1A.04: CORRELATES OF PERIPHERAL BLOOD MITOCHONDRIAL DNA COPY NUMBER IN A GENERAL POPULATION. J Hypertens (2015) 0.79

3C.09: STRATEGIES FOR CLASSIFYING PATIENTS BASED ON OFFICE, HOME AND AMBULATORY BLOOD PRESSURE MEASUREMENT. J Hypertens (2015) 0.78

Prevalence and persistency of orthostatic blood pressure fall in older patients with isolated systolic hypertension. Syst-Eur Investigators. J Hum Hypertens (1996) 0.78

Hypertension Optimal Treatment (HOT) trial. Lancet (1998) 0.77

Relationships of heart rate and heart rate variability with conventional and ambulatory blood pressure in the population. J Hypertens (2001) 0.77

8B.01: META-ANALYSIS OF FIVE PROSPECTIVE AND RANDOMIZED CONTROLLED TRIALS OF RENAL SYMPATHETIC DENERVATION ON OFFICE AND AMBULATORY SYSTOLIC BLOOD PRESSURE IN TREATMENT RESISTANT HYPERTENSION. J Hypertens (2015) 0.77

Intra-erythrocyte cation concentrations in relation to the C1797T beta-adducin polymorphism in a general population. J Hum Hypertens (2007) 0.77

Detection of cerebral aging, an absolute need: predictive value of cognitive status. Eur Neurol (1998) 0.76

Short report: low-level lead exposure does not increase the blood pressure in the general population. Cadmibel Study Group. J Hypertens (1993) 0.76

[Treatment of isolated systolic arterial hypertension and prevention of dementia in aged patients. The Syst-Eur multicenter study]. Arch Mal Coeur Vaiss (1999) 0.76

Renal artery stenosis: evaluation with intravenous digital subtraction angiography. Radiology (1986) 0.76

A plea for harmonising guidelines. Int J Cardiol (2001) 0.76

Critical appraisal of the JNC VI, WHO/ISH and BHS guidelines for essential hypertension. Expert Opin Pharmacother (2000) 0.76

Blood pressure-measuring devices: time to open Pandora's box and regulate. Hypertension (2000) 0.76

Arterial properties in relation to genetic variation in alpha-adducin and the renin-angiotensin system in a White population. J Hum Hypertens (2008) 0.76

Blood pressure, cardiovascular outcomes and sodium intake, a critical review of the evidence. Acta Clin Belg (2013) 0.76

Inverse association between baseline pressure and benefit from treatment in isolated systolic hypertension. Hypertension (1994) 0.75

Blood pressure in very old subjects: a dilemma for the clinician. Eur Heart J (1998) 0.75

What does STOP-2 tell us about management of hypertension? Lancet (2000) 0.75

Hypertension and lead exposure. JAMA (1996) 0.75

Definition of new targets in cardiovascular prevention from young into old age. Eur Heart J (2002) 0.75

Participation rate in the Belgian population study on ambulatory blood pressure monitoring. J Hypertens (1996) 0.75

Antihypertensive drugs and cognitive function in older people. J Am Geriatr Soc (1998) 0.75

1D.03: INACTIVE MATRIX GLA PROTEIN IS ASSOCIATED WITH RENAL RESISTIVE INDEX IN A POPULATION-BASED STUDY. J Hypertens (2015) 0.75

Antiproteinuric effects of cilnidipine. Kidney Int (2008) 0.75

[OP.7C.07] DIASTOLIC LEFT VENTRICULAR FUNCTION IN RELATION TO COLLAGEN-SPECIFIC URINARY AND SERUM COLLAGEN BIOMARKERS IN A GENERAL POPULATION. J Hypertens (2016) 0.75

[OP.1B.01] VITAMIN K DEPENDENT PROTECTION OF RENAL FUNCTION IN MULTI-ETHNIC POPULATION STUDIES. J Hypertens (2016) 0.75

Blood pressure measurement in the year 2008: revival of oscillometry? Neth J Med (2008) 0.75

[OP.1B.10] RISK SCORE FOR INCIDENT HEART FAILURE: A SUBJECT-LEVEL META-ANALYSIS FROM THE HEART 'OMICS' IN AGEING (HOMAGE) DATABASE. J Hypertens (2016) 0.75

Benefit of antihypertensive treatment in the diabetic patients enrolled in the Systolic Hypertension in Europe (Syst-Eur) trial. Cardiovasc Drugs Ther (2000) 0.75

8A.02: THE ASSOCIATION OF LEFT VENTRICULAR AND ATRIAL STRUCTURE WITH BODY COMPOSITION: IMPACT AND PITFALLS OF SCALING IN POPULATION BASED STUDIES. J Hypertens (2015) 0.75

Short-term morphologic results of percutaneous transluminal renal angioplasty as determined with angiography. Radiology (1989) 0.75

Treatment of diabetic patients with hypertension. Curr Hypertens Rep (1999) 0.75

[OP.7D.07] INFLUENCE OF RENAL SYMPATHETIC DENERVATION ON BLOOD PRESSURE VARIABILITY: EXPERIENCE AT 11 EUROPEAN EXPERT CENTERS. J Hypertens (2016) 0.75

Genetic variation and environmental factors in biological and arterial ageing. Verh K Acad Geneeskd Belg (2008) 0.75

Relationship between systemic haemodynamics and glucose tolerance in patients with essential hypertension. J Hypertens Suppl (1991) 0.75

1C.06: AMBULATORY PULSE PRESSURE IS NEGATIVELY ASSOCIATED WITH EXCRETIONS OF URINARY CAFFEINE AND ITS METABOLITES. J Hypertens (2015) 0.75

Diagnosis and treatment of hypertensive disorders during pregnancy. Acta Clin Belg (2010) 0.75

Clinical trials in isolated systolic hypertension. Curr Hypertens Rep (1999) 0.75

[Hypertension as a source of cognitive regression, or dementia]. Ned Tijdschr Geneeskd (2007) 0.75